PTC Therapeutics
PTCT
#3138
Rank
C$6.75 B
Marketcap
C$80.91
Share price
-3.27%
Change (1 day)
-24.05%
Change (1 year)

EPS for PTC Therapeutics (PTCT)

EPS in 2026 (TTM): C-$1.78

According to PTC Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$1.88. In 2025 the company made an earnings per share (EPS) of C$12.60 an increase over its 2024 EPS that were of C-$6.78.

EPS history for PTC Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.78-114.09%
2025C$12.60-285.84%
2024C-$6.78
2022C-$11.174.85%
2021C-$10.65
2019C-$6.4166.17%
2018C-$3.8629.33%
2017C-$2.98-50.12%
2016C-$5.98-17.59%
2015C-$7.2657.63%
2014C-$4.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$7.53-500.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
C$22.47-1,296.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C-$2.25 19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C-$3.77 100.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C-$1.51-19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C-$5.99 219.08%๐Ÿ‡บ๐Ÿ‡ธ USA